2023 Partnering in Patents | Pre-Meeting Event
2023 Partnering in Patents October- Virtual
October 18, 2023 10:00 AM to 3:30 PM
Location
Credits
No CLE
Registration
The USPTO and AIPLA are hosting the 30th Annual Partnering in Patents event remotely as a pre-conference event to our Annual Meeting. This virtual, one day program fosters an open dialog between AIPLA members and the USPTO.
The program has two parts: a morning focus session, and the afternoon program. There is a separate registration for each part. Links to both are below.
AGENDA
10:00-11:30 AM virtual focus session - (This session is full, however you may still register for the afternoon panels.)
In virtual roundtables, a mix of practitioners and USPTO members will discuss 3-4 topics to generate ideas and best-practice suggestions. These sessions are limited to 80 participants. If you are interested in this session, please register using the separate link above. We are looking for an even number of outside practitioners and USPTO participants.
12:00-3:30 - Welcome remarks followed by three 1-hour panels (no seat limit): To register for the afternoon panels, please click here.
- USPTO updates on programs and initiatives
- Prosecution perspectives from a panel of PTO personnel and practitioners
- Interactive quiz show and discussion of past focus session topics
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.